Inhibitory action of gemfibrozil on cholesterol absorption in rat intestine

Y Umeda1, Y Kako, K Mizutani

  • 1Department of Pediatrics, Showa General Hospital, Japan.

Insights

Gemfibrozil was found to inhibit intestinal cholesterol absorption in rats. This lipid-lowering drug reduced the transport of cholesterol from the intestine into the lymph.

Area of Science:

  • Pharmacology
  • Gastroenterology
  • Lipid Metabolism

Background:

  • Gemfibrozil is a lipid-lowering drug used to treat hyperlipidemia.
  • Understanding its effects on intestinal lipid absorption is crucial for its therapeutic application.

Purpose of the Study:

  • To investigate the effect of gemfibrozil on intestinal lipid absorption in rats.
  • To determine if gemfibrozil inhibits the absorption of cholesterol and triglycerides.

Main Methods:

  • Male Sprague-Dawley rats were administered gemfibrozil orally for 14 days.
  • Radiolabeled triolein and cholesterol were infused intraduodenally, along with gemfibrozil.
  • Lymphatic and intestinal levels of radioactivity were measured to assess lipid absorption.

Main Results:

  • Gemfibrozil significantly reduced lymphatic cholesterol transport.
  • More radioactive cholesterol remained in the intestinal lumen and mucosa of gemfibrozil-treated rats.
  • While triglyceride transport was not significantly affected, more triglycerides remained in the intestinal lumen.

Conclusions:

  • Gemfibrozil inhibits cholesterol absorption in the rat intestine.
  • The drug increases biliary cholesterol excretion.
  • These findings suggest a direct impact of gemfibrozil on intestinal lipid handling.

Related Concept Videos

Glucose Absorption Into the Small Intestine01:26

Glucose Absorption Into the Small Intestine

Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and 'exit' via the...
Drug Absorption: Factors Affecting GI Absorption01:19

Drug Absorption: Factors Affecting GI Absorption

The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.
In...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Factors Influencing Drug Absorption: Disease States and Pharmacology01:25

Factors Influencing Drug Absorption: Disease States and Pharmacology

Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry01:20

Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry

Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
Hepatic Drug Clearance: Role of Transporters01:14

Hepatic Drug Clearance: Role of Transporters

In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...